“Abortion providers are herding women in and out of their clinics, in many cases without so much as an in-person consultation,” said AUL’s Dr. Charmaine Yoest. “This isn’t just bad for women— it’s patient abandonment.”
WASHINGTON, D.C. (10-04-13) – Americans United for Life filed an amicus brief today in the North Dakota Supreme Court on behalf of 49 state legislators in favor of a law that would protect women’s health by regulating sometimes dangerous life-ending drugs, according to FDA protocols. A lower court invalidated the 2011 law, based on AUL model legislation, after the abortion industry fought to remain unregulated.
“Abortion providers are herding women in and out of their clinics, in many cases without so much as an in-person consultation. This isn’t just bad for women—it’s patient abandonment,” said AUL President and CEO Dr. Charmaine Yoest. “AUL’s legal team is supporting the courageous legislators’ work in MKB Management v. Burdick as we all work to put women’s health over abortion industry profits.”
At least eight women have died from bacterial infections after administering abortion-inducing drugs in an unapproved manner, and there have been more than 2,000 other adverse medical events reported to the FDA following chemical abortions. Relying on information about the potential dangerous impact of these drugs, North Dakota legislators, including the bill’s primary sponsor Representative Bette Grande, sought to protect women by requiring that abortion providers abide by the guidelines issued by the FDA.
“Big Abortion should be ashamed to be fighting, lobbying, and litigating to sell life-ending drugs in ways that have resulted in women’s deaths,” said Dr.Yoest.
AUL’s amicus brief (available here) demonstrates that the trial court made legal and factual errors that undermine its entire decision, and that U.S. Supreme Court precedent clearly supports abortion regulations designed to protect women’s health.
